key: cord-0275176-ywyxm0yx
authors: Zeleznik, O.; Kang, J. H.; Lasky-Su, J. A.; Eliassen, A. H.; Frueh, L.; Clish, C.; Rosner, B. A.; Elze, T.; Hysi, P.; Khawaja, A. P.; Wiggs, J. L.; Pasquale, L. R.
title: Plasma metabolomics of primary open-angle glaucoma in three prospective US cohorts and the UK Biobank.
date: 2022-02-28
journal: nan
DOI: 10.1101/2022.02.24.22271483
sha: bff0cf97405ebc3433821534665cbc05bc7ae68f
doc_id: 275176
cord_uid: ywyxm0yx

Purpose: To better understand the etiologic pathways in glaucoma, we aimed to identify pre-diagnostic plasma metabolites associated with glaucoma risk. Methods: In a case-control study from the Nurses Health Study (NHS), NHSII and Health Professionals Follow-Up Study (HPFS), 599 incident primary open-angle glaucoma (POAG) cases (mean time between blood draw and diagnosis was 10.3 years) were 1:1 matched to 599 controls. Plasma metabolites were measured with LC-MS/MS at the Broad Institute (Cambridge, MA, USA); 367 metabolites from 17 metabolite classes passed quality control analyses. For comparison, in a cross-sectional study in the UK Biobank, 168 NMR metabolites (Nightingale, Finland; version 2020) were measured in serum samples from 2,238 prevalent glaucoma cases and 44,723 controls. Metabolites were probit-score transformed for normality; multiple logistic regression was used to identify metabolites associated with POAG in NHS/NHSII/HPFS and glaucoma in UK Biobank. In NHS/NHSII/HPFS, we also used Metabolite Set Enrichment Analysis to identify metabolite classes associated with POAG. All analyses adjusted for established glaucoma risk factors. False discovery rate (FDR) and number of effective tests (NEF) were used to adjust for multiple comparisons. Results: Nine metabolite classes were associated (FDR<0.05) with POAG in NHS/NHSII/HPFS: triglycerides, diglycerides, two lysophospholipids classes [lysophosphatidylcholines and lysophosphatidylethanolamines], and two phospholipid class [phosphatidylethanolamines and phosphatidylcholines] were positively associated, while cholesteryl esters, carnitines, and organic acids and derivatives were inversely associated with POAG risk; further adjustment for covariates minimally altered the results. These associations were particularly stronger for POAG with paracentral visual field loss. In the UK Biobank, notably, triglycerides and phospholipids (from which lysophospholipids are derived through hydrolysis), were confirmed to be associated (p<0.05) with higher glaucoma risk. Also, in the UK Biobank, the metabolites of tyrosine, glucose, and glutamine were positively associated (NEF<0.2) while 3-hydroxybutyrate, acetate, citrate, pyruvate and lactate (the latter 4 being anionic organic acids) were inversely associated with glaucoma (NEF<0.05). Conclusions: Higher levels of glycerides (diglycerides and triglycerides) and phospholipids were adversely associated with glaucoma in both the NHS/NHSII/HPFS and the UK Biobank, suggesting that they play an important role in glaucoma pathogenesis.

Glaucoma is a progressive optic neuropathy that is a leading cause of irreversible blindness worldwide. 1 Primary open-angle glaucoma (POAG) is the most common form, and yet the etiology of this multifactorial disease is poorly understood. Genome-wide association studies have identified >120 genetic loci for POAG, 2 and the finding of multiple genes in various pathways suggests that there is a complex metabolic network that affects optic nerve health.

The metabolome is the set of small molecule metabolites that are critical for growth and maintenance of cells and tissues, 3, 4 and represent the end products of environmental factors and gene expression associated with responses to such factors. Metabolomics platforms quantify blood metabolites and can be used to evaluate the etiologic role of metabolic alterations. Multiple proteomic and metabolomics studies of prevalent POAG/glaucoma have been conducted, [5] [6] [7] [8] [9] and some novel markers have been found to be associated with POAG. However, this approach may be problematic for the discovery of changes related to early disease, as consequences of advanced disease or treatment are likely to impact circulating metabolite profiles with the use of prevalent glaucoma cases. In this study, we included 599 incident cases and 599 matched controls in a nested case-control study of pre-diagnostic circulating plasma metabolites from ~10 years before POAG diagnosis, and to confirm the findings, we evaluated the metabolomic data in prevalent cases in the UK Biobank.

We conducted a nested case-control study in the NHS, NHSII and HPFS cohorts from the US.

The NHS was initiated in 1976 with 121,700 female registered nurses aged 30-55 years at enrollment; the NHSII began in 1989 with 116,429 female registered nurses aged 25-42 years, and the HPFS was launched in 1986 with 51,529 male health professionals aged 40-75 years. Participants have completed biennial questionnaires that asked about lifestyle and medical conditions, such as glaucoma. POAG cases were identified among participants who self-reported a physician diagnosis of glaucoma on biennial . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 28, 2022. ;  https://doi.org/10.1101/2022.02.24.22271483 doi: medRxiv preprint questionnaires. To confirm the self-reports of glaucoma, we asked participants for their consent to obtain relevant medical records from their treating providers. All eye care providers of record were requested to send all available visual fields (VFs) and were mailed a supplementary questionnaire to complete and return. A glaucoma specialist (LRP) reviewed the questionnaire (or medical records sent instead of questionnaires) as well as the VFs in a standardized manner. This questionnaire included items about untreated maximum IOP, any secondary causes of high untreated IOP, filtration angle, structural features of the optic nerve, glaucoma surgery, any VF loss and any secondary conditions that may cause VF loss.

Cases we included in analyses had at least two reliable VFs (≤ 20% for false negative rate and false positive rate and ≤ 33% for fixation loss rate) that showed reproducible defects consistent with glaucoma, non-occludable angles in both eyes, and no secondary causes of IOP elevation (e.g., trauma, uveitis, exfoliation syndrome, pigment dispersion syndrome evident on biomicroscopic anterior segment examinations At baseline (2006-2010), participants completed a touch screen questionnaire and were considered to have glaucoma if in response to the question, "Has a doctor told you that you have any of the following problems with your eyes?", they chose glaucoma from the menu. Participants were also considered to have glaucoma if they reported a history of glaucoma surgery or laser on the questionnaire or if they carried an ICD9/10 code for glaucoma (ICD 9: 365.*; ICD10: H40.** (excluding H40.01* and H42.*)).

As described previously, 10-12 plasma metabolites were profiled using liquid chromatography tandem mass spectrometry (LC-MS) to measure endogenous, polar metabolites and lipids (Broad Institute of MIT and Harvard University (Cambridge, MA)). Among 427 known metabolites, we excluded 60 that were impacted by delayed blood processing, 13 leaving 367 metabolites for analyses. For metabolites with <10% missing across participant samples, missing values were imputed with 1/2 of the minimum value measured for that metabolite as has been done in prior studies. 14 All but one included metabolite exhibited good within person reproducibility over a 1-year period, indicating that one blood sample provides a . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted February 28, 2022. ; https://doi.org/10.1101/2022.02.24.22271483 doi: medRxiv preprint reasonable measure of longer-term exposure (312 out of 313 available 1 year Pearson or intraclass correlations were >0.4). 13 For 317 (out of 367) metabolites, they were each assigned a metabolite class (30 in total) based on chemical taxonomy; we evaluated 17 metabolite classes which included at least 3 metabolites: steroids and steroid derivatives; carnitines; diglycerides (DGs); triglycerides (TGs); cholesteryl esters; lysophosphatidylethanolamines (LPEs); phosphatidylethanolamines (PEs); lysophosphatidylcholines (LPCs); phosphatidylcholines (PCs); phosphatidylcholine plasmalogens; phosphatidylethanolamines plasmalogens; organoheterocyclic compounds; ceramides; carboxylic acids and derivatives; organic acids and derivatives; nucleosides, nucleotides, and analogues; and sphingomyelins. Metabolite values were transformed to probit scores to scale to the same range and to minimize the influence of skewed distributions. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted February 28, 2022. ; https://doi.org/10.1101/2022.02.24.22271483 doi: medRxiv preprint

Given the matched design, for the individual metabolite analyses and metabolite class analyses, in successive models, we used nested multivariable-adjusted conditional logistic regression models. Model 1 did not adjust for any covariates and evaluated the matched data as is. In Model 2, we adjusted for factors as of blood draw that have a major influence on metabolites and a subset of matching factors where there was imperfect matching between cases and controls (e.g., cohort/sex was perfectly matched, but age was not, so was additionally adjusted for): age (years; matching factor), month of blood draw (matching factor), time of blood draw (matching factor), fasting status (>8 hours or less; matching factor), body mass index (BMI, kg/m 2 ), smoking status (never, past, current), and physical activity (metabolic equivalents of task-hours/week). In Model 3, we further added established risk factors for POAG: glaucoma family history, ancestry (non-Hispanic white, black, Asian, Hispanic white), index of socioeconomic status based on 7 census-tract variables and for women: age at menopause (linear age). In Model 4, we added additional POAG risk factors of intake of nitrate, 18 caffeine, 19 alcohol, 20 Alternate Healthy Eating Index excluding alcohol, 21 and total caloric intake. In Model 5, we further added comorbidities associated with POAG: hypertension, high cholesterol, diabetes, oral steroid use.

As data from the UK Biobank was used to evaluate whether the results from the NHS/NHSII/HPFS are reproduced in an independent population, we used multiple logistic regression to evaluate the association between metabolite levels in relation to prevalent glaucoma. The multiple logistic regression model adjusted for age and age-squared (years; to finely control for age), sex, ethnicity (Caucasian, Black and other), smoking status (never, past and current smoker), number of cigarettes smoked daily among current smokers, alcohol intake frequency (daily or almost daily, 3-4 times a week, 1-2 times a week, 1-3 times a month, special occasions only, never), coffee and tea consumption (cups per day), physical activity (Metabolic Equivalent of Task (MET)-hours/week), Townsend deprivation index . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 28, 2022. ; https://doi.org/10.1101/2022.02.24.22271483 doi: medRxiv preprint (range: -6 to 11; a higher index score indicates more relative poverty for a given residential area), BMI (kg/m 2 ), systolic blood pressure (mm Hg), history of diabetes (yes or no), history of cardiovascular disease, systemic beta blocker use, use of statin drugs and spherical equivalent. We included 46,961 participants (2238 glaucoma cases and 44,723 controls) with complete data on metabolites and covariates.

All analyses were performed with SAS 9.4 and R 3.4.1. For analyses of individual metabolites, metabolite values were used as continuous variables (per 1 standard deviation (SD) increase) to calculate linear trend p-values. We estimated the odds ratios (OR) and 95% confidence intervals (CIs) per 1 SD increase in metabolite levels.

For evaluating individual metabolites, "number of effective tests" (NEF) 22 was used to adjust for multiple comparisons as NEF has the advantage of accounting for the high correlation structure of the metabolomics data. NEF-p<0.05 was considered statistically significant and NEF-p<0.2 was considered worthy of additional analysis given that this was an exploratory study.

For NHS/NHSII/HPFS, for metabolite class analyses, Metabolite Set Enrichment Analysis was used. As metabolite classes overall are not correlated, to adjust for multiple comparisons, False Discovery Rate (FDR) 23 was used. FDR<0.05 was considered statistically significant, while FDR<0.2 was considered nominally significant and worth considering in future analyses given the hypothesisgenerating aspect of this study.

Among 599 cases, 74.3% were female, with a mean (SD) age at blood draw of 58.0 (SD=8.0) years and at diagnosis of 68.3 (SD=9.2) years. Mean time between blood draw to diagnosis was 10.3 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 28, 2022. ; https://doi.org/10.1101/2022.02.24.22271483 doi: medRxiv preprint years. Controls were similar to cases for the matching factors. Distributions of POAG risk factors were generally in the expected directions for cases and controls ( Table 1) .

Supplementary Table S1 presents the individual associations between the 367 metabolites and POAG; 6 metabolites that were at least nominally significant at p<0.05 in any of the models (Model 1 through Model 5) are plotted in Figure 1 . In Model 1 (model incorporating matching) results, all 6 metabolites were nominally significant, including two diglycerides (DG(36:2), DG(34:1)), one triglyceride (TG(52:2)), two LPCs (LPC(16:0) and Na_LPC(16:0)) and one LPE(16:0); of these, LPE(16:0), TG(36:2), TG(52:2) and Na-LPC(16:0) were NEF-p<0.2. In successive models, the associations were generally similar, although the significance was attenuated with additional adjustment for covariates. In Model 2, where we more finely adjusted for matching factors (e.g., fasting status, time of day) and other major determinants of variability in metabolites, such as BMI, only the glycerides were NEF-p<0.2. However, in successive models of Model 3 and 4 (addition of POAG established and suspected risk factors), and Model 5 (further adjust for co-morbidities), we observed that while none of the metabolites were NEF<0.05, all were nominally significant and the direction of associations for the metabolites was similar. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 28, 2022. ; https://doi.org/10.1101/2022.02.24.22271483 doi: medRxiv preprint inverse associations with cholesteryl esters and organic acids and derivatives (which includes amino acids) were robust and FDR-significant. For carnitines and phosphatidylethanolamines, the FDR was ≥ 0.2 and for PCs and triglycerides, the FDR was <0.2; interestingly, in Model 5, an inverse association with sphingomyelins was observed at FDR<0.2.

POAG is multifactorial and clinically heterogeneous. Investigating heterogeneity in VF loss patterns for POAG may provide new etiologic insights as different types of optic nerve damage manifest as distinct VF loss patterns. For example, glaucomatous paracentral scotomas have been associated with more systemic risk factors compared to peripheral VF loss. [24] [25] [26] Therefore, we separately evaluated the associations between metabolite classes and POAG defined by VF loss patterns (paracentral (Figure 3a; n=178 cases) versus peripheral VF loss (Figure 3b; n=331 cases) ); of the 599 cases, VF loss pattern derived from Humphrey visual field test were available in 509 cases. As shown in Figure 3a and Figure   3b , overall, more metabolite classes (9 classes versus 5 classes) were significantly associated with POAG with paracentral VF loss versus peripheral VF loss. In addition to the three classes associated with peripheral VF loss -namely diglycerides, LPCs, and LPEs -for POAG with paracentral VF loss, the classes of triglycerides, PEs, and PCs were also adversely associated at FDR<0.05. In addition to cholesteryl esters and organic acids and derivatives being inversely associated with POAG with peripheral VF loss, the class of carnitines was also inversely associated with POAG with paracentral VF loss at FDR<0.05.

Because prior studies of triglycerides in relation to health outcomes 27, 28 have observed differing associations by the degree of saturation and number of carbon atoms, in exploratory analyses, we further plotted the associations as a function of the number of double bonds in triglycerides and the number of carbon atoms. Interestingly, as found with diabetes and cardiovascular disease, 27, 28 in general, those . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 28, 2022. ; https://doi.org/10.1101/2022.02.24.22271483 doi: medRxiv preprint triglycerides with fewer carbon atoms and double bonds were adversely associated with POAG risk while those with higher carbon atoms and double bonds were inversely associated with POAG risk (Figure 4 ).

To evaluate whether associations differed by subgroups, in exploratory analyses, we assessed whether results varied by age (Supplementary Figure S1) , sex (Supplementary Figure S2) , BMI (Supplementary Figure S3) , time to diagnosis (Supplementary Figure S4) , and history of glaucoma (Supplementary Figure S5) . Although no major differences were observed in various subgroups, there were some suggestions that the associations were strongest in those with BMI>25 kg/m 2 and those diagnosed within the decade after blood draw.

To assess whether the associations observed in NHS/NHS2/HPFS might also be observed in the UK Biobank, we conducted metabolomic analyses of the outcome of glaucoma, defined based on selfreported glaucoma, use of glaucoma medications and ICD codes (2238 glaucoma cases and 44723 noncases). In general, glaucoma cases were older, had more diabetes, and higher systolic blood pressure ( Table 2 ).

In multivariable-adjusted analyses of individual metabolites (Figure 5; Supplementary Table   S2 ), we observed that 8 triglyceride metabolites as well as phospholipids (from which lysophospholipids are derived through hydrolysis) were nominally associated with higher glaucoma risk; tyrosine (NEF<0.05) and glucose (NEF<0.05) were significantly associated with higher glaucoma risk, while specific organic acids and derivatives, such as acetate, 2-hydroxybutyrate, citrate, pyruvate and lactate were inversely associated at NEF<0.05. (In NHS/NHS2/HPFS (Supplementary Table S1), tyrosine and valine were included as carboxylic acids and derivatives; glutamine and phenylalanine were included as organic acids and derivatives; however, glucose, acetate, 3-hydroxybutyrate, citrate, pyruvate and lactate data were not available).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 28, 2022. ; https://doi.org/10.1101/2022.02.24.22271483 doi: medRxiv preprint

In this nested case-control study of pre-diagnostic plasma metabolites in relation to POAG (n=1198), with a mean 10.3 years between blood draw and diagnosis, we observed that higher levels of diglycerides, triglycerides and phospholipids were adversely associated with POAG in the NHS/NHSII/HPFS, with stronger associations for POAG with paracentral VF loss. The adverse associations with glycerides and phospholipids in relation to prevalent glaucoma were confirmed in the cross-sectional UK Biobank, underscoring their importance in the etiology of glaucoma. While this study was the first to evaluate the relation between pre-diagnostic plasma metabolites, the replication of our findings in a prevalent glaucoma dataset do support a role for altered lipid regulation in glaucoma.

A systematic review 9 has identified 13 studies to date on the metabolomics of open-angle glaucoma. Of these, 3 evaluated serum, 29 30 ), our study was unique in that the sample size in NHS/NHS2/HPFS was the largest to date (599 cases and 599 controls), did not use convenience sample of controls (e.g., those with cataract or other non-glaucoma eye conditions) and importantly, evaluated pre-diagnostic plasma collected a mean of 10.3 years before diagnosis for POAG cases versus evaluating blood samples from prevalent or newly diagnosed cases, which may be affected by disease or treatment. In addition, our study evaluated metabolomic and glaucoma data from the UK Biobank, to provide independent confirmation of findings, although the metabolomics platforms did not overlap substantially. Nonetheless, the nominal replication of adverse associations between selected lipid species with glaucoma is remarkable as the assay systems were fundamentally different: LC-MS in NHS/NHS2/HPFS vs NMR spectroscopy in UK Biobank. Of note, the systematic review identified 12 metabolites that have been identified across the various metabolomics studies as being associated with open-angle glaucoma in at least 2 studies; of these, two were phospholipids (PCs), 2 were organic acids and derivatives (including amino acids), and 2 were carnitines. 9 Our results are consistent with prior studies in identifying phospholipids and various organic . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 28, 2022. ; https://doi.org/10.1101/2022.02.24.22271483 doi: medRxiv preprint acids and derivatives in both the NHS/NHS2/HPFS and UK Biobank, while also showing support for the role of lipids, particularly diglycerides, triglycerides and other lipids (e.g., cholesteryl esters).

The relation between triglycerides and glaucoma has been conflicting, with studies showing an adverse association, 41 inverse association 42 Our study confirmed this adverse association between higher triglycerides and POAG risk in two populations. This finding is consistent with the discovery of POAG loci near genes related to cholesterol metabolism (ABCA1 and CAV1/2). One biological mechanism for this association may be intraocular pressure-related: hypertriglyceridemia can lead to increased blood viscosity, which causes elevation of episcleral venous pressure 45, 46 and higher IOP. Indeed, a review 44 reported that higher triglyceride level was significantly associated with modest increases of IOP. Interestingly, we observed that the relationship with triglycerides were complex. Triglycerides that are shorter and more saturated were adversely associated while those that are longer and are more unsaturated were inversely associated with POAG, possibly because such triglycerides may be markers of a healthier cardiometabolic profile. 28 Finally, triglycerides showed stronger associations with POAG with paracentral VF loss than that with peripheral loss, further underscoring the observation that this subtype is more strongly associated with systemic factors. As for cholesteryl esters, there is limited data in relation to glaucoma; however, it is known that the ratio of cholesterol to esterified cholesterol is altered with age and in several neurodegenerative diseases. 47 

We observed adverse associations between several phospholipid classes and POAG risk. PCs/PEs and their partial hydrolysis products, LPCs/LPEs, are implicated in aging [48] [49] [50] as well as type 2 diabetes 51 , . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 28, 2022. ; https://doi.org/10.1101/2022.02.24.22271483 doi: medRxiv preprint and play key roles in mitochondrial dynamics. 52 PEs and PCs are abundant membrane phospholipids that provide membrane structure and facilitate vacuolar delivery and cytokinesis. However, LPCs are proinflammatory and pro-oxidant, 53 and they may play a role in the autotaxin-lysophophatidic acid pathway in intraocular pressure regulation. 35, 37, [54] [55] [56] [57] Our results are consistent with other targeted lipidomic studies of glaucoma that have revealed higher specific phospholipids in blood, 9 the trabecular meshwork or aqueous humor of glaucomatous eyes. 55, 56, 58, 59 

Mitochondrial dysfunction has been hypothesized as a key component of POAG pathophysiology. [60] [61] [62] [63] [64] [65] [66] Plasma metabolomic markers of mitochondrial function may include acylcarnitines, which transport acyl-groups (organic acids and fatty acids) into the mitochondria so that they can be broken down to produce energy in a process known as beta-oxidation. In our study, POAG cases had lower levels of acylcarnitines, particularly the long-chain acylcarnitines. Interestingly, high-fructose diets were associated with a decrease in long-chain acylcarnitines, suggesting a decrease in mitochondrial βoxidation and an increase in lipid peroxidation, which also led to higher triglycerides. 67 Carnitine has also been shown to be neuroprotective in a glaucoma animal model. 68 This is consistent with several crosssectional studies of glaucoma that have also identified alterations in the carnitine pool. 33, 35, 69 Related to the importance of mitochondrial health, greater use as an energy source of ketone bodies, such as higher 3-hydroxybutyrate versus glucose may also be important. In the UK Biobank, a higher level of 3-hydroxybutyrate was inversely associated with POAG risk. Ketone bodies have been associated with greater mitochondrial efficiency and have neuroprotective properties. 70 This is consistent with a large genetic pathway analysis study that identified the butanoate pathway, which is involved in generating precursors for ketone bodies, as being important for POAG etiology, 71 a study that observed suggestive lower risk of POAG with paracentral VF loss with a plant-based low carbohydrate diet 72 and another study analyzing genes encoding mitochondrial proteins that implicated lipid and carbohydrate metabolism as being important in POAG. 73 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 28, 2022. ; https://doi.org/10.1101/2022.02.24.22271483 doi: medRxiv preprint Among the most inversely associated organic acids and derivatives were N1-Acetylspermidine and N1,N12-Diacetylspermine (Supplementary Table S1 ). Spermine and spermidine are amines that also regulate mitochondrial membrane potential and have neuroprotective effects; 33 these metabolites have also been inversely associated with POAG in the study by Leruez et al. 33 Tyrosine is another that has been identified by Leruez et al. 33 and was found to be associated with glaucoma in the UK Biobank and thus warrants further study.

A limitation of our data is that our NHS/NHS2/HPFS study population was relatively homogeneous, with mostly White health professionals; therefore, our findings may not be generalizable to other populations with different race and ethnicity composition. Additionally, there may have been residual confounding by other unmeasured factors. A further potential limitation is that our blood samples were collected at one timepoint; However, we included only those metabolites with good correlations for within person stability over at least 1 year. In addition, the UK Biobank data was cross-sectional and included prevalent cases of glaucoma, who would have been comprised mostly of POAG cases, but may have also included those with other types of glaucoma, which would have led to biases due to disease misclassification. Also, there was the possibility in the UK Biobank that metabolite levels may have been influenced by glaucoma treatment; thus, our results need to be interpreted cautiously. However, the confirmation of the associations with triglycerides and phospholipids provided support to the prospective associations observed in NHS/NHS2/HPFS.

Our study had several strengths. To our knowledge, our study in NHS/NHS2/HPFS is the first study assessing the associations of pre-diagnostic metabolites collected ~ 10 years before diagnosis and POAG risk, with a relatively large sample size of 599 cases and 599 matched controls. Additional strengths include the detailed covariate information and long time between blood draw and diagnosis date (mean=10.3 years) and the availability of the UK Biobank data to confirm findings.

Overall, these results provide new insights into the etiology of POAG. Our data implicate dysregulation in lipid metabolism and mitochondrial function in glaucoma etiology and suggest new targets for glaucoma prevention or therapies.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 28, 2022 Abbreviation: MET=metabolic equivalent of task * Values are means ± standard deviation or numbers (percentages), are standardized to the age distribution of the study population and based on those with non-missing values. † Cases and controls were 1:1 matched based on age (all >40 years), cohort/sex, month and year of blood collection, time of day of blood draw, fasting status (> or ≤ 8 hours), race/ethnicity, and among women: additional matching on menopausal status and hormone therapy use at blood draw (premenopausal, postmenopausal and on hormone therapy (HT), postmenopausal and not on HT, missing/unknown) and at glaucoma diagnosis. All cases and controls reported eye exams in the index period of the matched cases' diagnosis date. ‡ Alternative Healthy Eating Index scores rang from 0 to 100; a higher score reflects a healthier diet.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 28, 2022. ; https://doi.org/10.1101/2022.02.24.22271483 doi: medRxiv preprint Figure 1 . Individual metabolites among the n=367 metabolites evaluated that were significant across the various nested multiple conditional logistic regression models of primary open-angle glaucoma (599 cases and 599 controls). Model 1: basic model, adjusting for matching factors only (see Table 1 ); Model 2 (factors that affect metabolite levels and matching factors as matching was imperfect): Model 1 + age, sex, smoking status, BMI, physical activity, time of day of blood draw, month of blood draw, fasting status; Model 3 (established risk factors for primary open-angle glaucoma (POAG)): Model 2 + family history of glaucoma, socioeconomic index based on census tract data, race/ethnicity and age at menopause; Model 4 (potential modifiable dietary risk factors for POAG): Model 3 + nitrate intake, caffeine intake, alcohol intake, caloric intake; Model 5 (systemic comorbidities / drugs suggested to be associated with POAG in some studies): Model 4 + hypertension, high cholesterol, diabetes and oral steroid use. * p<0.05; ** Number of effective tests (NEF)<0.2; *** NEF<0.05 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Table 1 ); Model 2 (factors that affect metabolite levels and matching factors as matching was imperfect): Model 1 + age, sex, smoking status, BMI, physical activity, time of day of blood draw, month of blood draw, fasting status; Model 3 (established risk factors for primary open-angle glaucoma (POAG)): Model 2 + family history of glaucoma, socioeconomic index based on census tract data, race/ethnicity and age at menopause; Model 4 (potential modifiable dietary risk factors for POAG): Model 3 + nitrate intake, caffeine intake, alcohol intake, caloric intake; Model 5 (systemic comorbidities / drugs suggested to be associated with POAG in some studies): Model 4 + hypertension, high cholesterol, diabetes and oral steroid use. * False Discovery Rate (FDR)<0.2; ** FDR<0.05; *** FDR<0.001 l 4

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Figure 2 ). Model 1: basic model, adjusting for matching factors only; Model 2 (factors that influence metabolites): age + smoking status + BMI + physical activity + time of day (as matching imperfect) + month of blood draw (season, as matching imperfect); Model 3 (established risk factors for POAG): M2 + family history of POAG + SES + race + age at menopause; Model 4 (established risk factors for POAG): M3 + nitrate intake + caffeine intake + alcohol intake + alternate healthy eating index + caloric intake; Model 5 (co-morbidities / drugs that have been associated with POAG): M4 + hypertension + high cholesterol + diabetes + oral/inhaled steroid use. * False Discover Rate (FDR)<0.2; ** FDR<0.05; *** FDR<0.001 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted February 28, 2022. ; https://doi.org/10.1101/2022.02.24.22271483 doi: medRxiv preprint Results are shown by the number of carbon atoms (fatty acyl chain length) and double bonds (saturation) of each triglyceride. Each triglyceride is represented by a circle. The color of the circle correlates with the association direction (red: positive, blue: inverse) and the size of the circle corelates with the statistical significance (larger circles represent smaller p-values).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted February 28, 2022. ; https://doi.org/10.1101/2022.02.24.22271483 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted February 28, 2022. ; https://doi.org/10.1101/2022.02.24.22271483 doi: medRxiv preprint Figure 5 . Individual metabolites (out of N=168) that were nominally significantly associated with prevalent POAG in the UK Biobank (2238 cases, 44723 controls) . Multiple logistic regression model includes age, sex, smoking status, physical activity, BMI, ethnicity, spherical equivalent, coffee consumption, tea consumption, alcohol intake, systolic blood pressure, cholesterol level, diabetes, coronary artery disease, and statin use. * p<0.05; ** Number of effective tests corrected p-value (NEF)<0.2; *** NEF<0.05 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted February 28, 2022. ; https://doi.org/10.1101/2022.02.24.22271483 doi: medRxiv preprint

Number of people with glaucoma worldwide

Genome-wide meta-analysis identifies 127 openangle glaucoma loci with consistent effect across ancestries

Metabolomics by numbers: acquiring and understanding global metabolite data

Targeted metabolomics

Increased homocysteine levels in tear fluid of patients with primary open-angle glaucoma

Shotgun proteomics reveals specific modulated protein patterns in tears of patients with primary open angle glaucoma naive to therapy

Differential protein expression in tears of patients with primary open angle and pseudoexfoliative glaucoma

Brain-derived neurotrophic factor in patients with normal-tension glaucoma

Metabolomics in Glaucoma: A Systematic Review

Association of Pseudoexfoliation With Systemic Vascular Diseases in a South Indian Population

Dimethylguanidino valeric acid is a marker of liver fat and predicts diabetes

Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-alpha

Reproducibility of metabolomic profiles among men and women in 2 large cohort studies

Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics

Automated quantum mechanical total line shape fitting model for quantitative NMR-based profiling of human serum metabolites

Association of Dietary Nitrate Intake With Primary Open-Angle Glaucoma: A Prospective Analysis From the Nurses' Health Study and Health Professionals Follow-up Study

Caffeine consumption and the risk of primary openangle glaucoma: a prospective cohort study

Prospective study of alcohol consumption and the risk of primary open-angle glaucoma

Alternative dietary indices both strongly predict risk of chronic disease

A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms

Controlling the false discovery rate: a practical and powerful approach to multiple testing

Comparison of risk factors for initial central scotoma versus initial peripheral scotoma in normal-tension glaucoma

Location of Initial Visual Field Defects in Glaucoma and Their Modes of Deterioration

Initial parafoveal versus peripheral scotomas in glaucoma: risk factors and visual field characteristics

Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study

Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans

Comprehensive measurements of hydroxylinoleate and hydroxyarachidonate isomers in blood samples from primary open-angle glaucoma patients and controls

Elevation of serum asymmetrical and symmetrical dimethylarginine in patients with advanced glaucoma

Gut microbiota compositional profile and serum metabolic phenotype in patients with primary open-angle glaucoma

Metabolome-Wide Association Study of Primary Open Angle Glaucoma

A Metabolomics Profiling of Glaucoma Points to Mitochondrial Dysfunction, Senescence, and Polyamines Deficiency

Metabolomic Profiling of Aqueous Humor in Glaucoma Points to Taurine and Spermine Deficiency: Findings from the Eye-D Study

Differentiation of soluble aqueous humor metabolites in primary open angle glaucoma and controls

Differential metabolic markers associated with primary openangle glaucoma and cataract in human aqueous humor

Changes in the Lipidomic Profile of Aqueous Humor in Open-Angle Glaucoma

Multi-Omics Approach for Studying Tears in Treatment-Naive Glaucoma Patients

Occipital proton magnetic resonance spectroscopy (1H-MRS) reveals normal metabolite concentrations in retinal visual field defects

Patients with Primary Open-Angle Glaucoma May Develop Ischemic Heart Disease More Often than Those without Glaucoma: An 11-Year Population-Based Cohort Study

The relationship between components of metabolic syndrome and open-angle glaucoma

The Association Between Primary Open Angle Glaucoma and Clustered Components of Metabolic Syndrome

Cholesterol homeostasis: a key to prevent or slow down neurodegeneration

Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's disease

Alzheimer's Disease Neuroimaging I. Serum Phosphatidylethanolamine and Lysophosphatidylethanolamine Levels Differentiate Alzheimer's Disease from Controls and Predict Progression from Mild Cognitive Impairment

Targeted lipidomics distinguishes patient subgroups in mild cognitive impairment (MCI) and late onset Alzheimer's disease (LOAD)

Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes

Mitochondrial phospholipids: role in mitochondrial function

The mechanisms of lysophosphatidylcholine in the development of diseases

A Plasma Metabolomic Signature of the Exfoliation Syndrome Involves Amino Acids, Acylcarnitines, and Polyamines

Role of the autotaxin-lysophosphatidic acid axis in glaucoma, aqueous humor drainage and fibrogenic activity

Autotaxin-Lysophosphatidic Acid Pathway in Intraocular Pressure Regulation and Glaucoma Subtypes

Alteration in Lysophospholipids and Converting Enzymes in Glaucomatous Optic Nerves

Phospholipid profiles of control and glaucomatous human aqueous humor

Comparative phospholipid profiles of control and glaucomatous human trabecular meshwork

Mitochondrial dysfunction in ocular disease: Focus on glaucoma

Mitochondrial Markers in Aging and Primary Open-Angle Glaucoma

Mitochondrial dysfunction and glaucoma

Oxidative stress and mitochondrial dysfunction in glaucoma

The role of oxidative stress in glaucoma

Oxidative and Anti-Oxidative Stress Markers in Chronic Glaucoma: A Systematic Review and Meta-Analysis

Vitamin B3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice

Changes in Plasma Acylcarnitine and Lysophosphatidylcholine Levels Following a High-Fructose Diet: A Targeted Metabolomics Study in Healthy Women

Carnitine reduces the lipoperoxidative damage of the membrane and apoptosis after induction of cell stress in experimental glaucoma

Multi-Omics Approach for Studying Tears in Treatment-Naive Glaucoma Patients

A ketogenic diet may offer neuroprotection in glaucoma and mitochondrial diseases of the optic nerve

Hypothesis-independent pathway analysis implicates GABA and acetyl-CoA metabolism in primary open-angle glaucoma and normalpressure glaucoma

Low-carbohydrate-diet scores and the risk of primary open-angle glaucoma: data from three US cohorts

Assessing the Association of Mitochondrial Genetic Variation With Primary Open-Angle Glaucoma Using Gene-Set Analyses